Brief: Nrx Pharmaceuticals Announces Signing Of A Data And Technical Information Agreement With Columbia University
19/12/2023 13:20
Dec 19 (Reuters) - NRX Pharmaceuticals Inc NRXP.O :
* NRX PHARMACEUTICALS ANNOUNCES SIGNING OF A DATA AND
TECHNICAL
INFORMATION AGREEMENT WITH COLUMBIA UNIVERSITY ACCESSING KEY
DATA DEMONSTRATING EFFICACY AND SAFETY OF INTRAVENOUS KETAMINE
FOR THE TREATMENT OF SUICIDAL DEPRESSION
* NRX PHARMACEUTICALS INC- NRX PLANS TO PRESENT DATA FROM
THESE
TWO TRIALS TO FDA IN SUPPORT OF A NEW DRUG APPLICATION TO BE
FILED IN Q1 2024
Source text for Eikon: ID:nPnb3qjcja
Further company coverage: NRXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NRX Pharmaceuticals
See all newsBrief: NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024
U.S. RESEARCH ROUNDUP-Cintas Corp, Sprouts Farmers market, Voya Financial
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery
U.S. STOCKS ON THE MOVE-Zebra Technologies, Ecolab, American Electric Power
NRX Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview